ASCP Corner September 30, 2008

Are Nutritional Supplements Ready for Prime Time?

David Mischoulon, MD, PhD; Maurizio Fava, MD

J Clin Psychiatry 2008;69(9):1497-1498

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Over the past 20 years, there has been a surge of clinical trials examining the safety and efficacy of natural compounds for psychiatric indications. These studies have produced encouraging evidence for several putative antidepressants such as S-adenosyl-L-methionine (SAMe), St. John’s wort (SJW), the omega-3 fatty acids, and folic acid.

There are about 45 published randomized controlled trials(RCTs) of SAMe monotherapy against placebo or tricyclic antidepressants(TCAs).